These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Benzodiazepine treatment of panic and agoraphobic symptoms: use, dependence, toxicity, abuse. Salzman C J Psychiatr Res; 1993; 27 Suppl 1():97-110. PubMed ID: 7908335 [TBL] [Abstract][Full Text] [Related]
27. Predictors of long-term benzodiazepine abstinence in participants of a randomized controlled benzodiazepine withdrawal program. Voshaar RC; Gorgels WJ; Mol AJ; van Balkom AJ; Mulder J; van de Lisdonk EH; Breteler MH; Zitman FG Can J Psychiatry; 2006 Jun; 51(7):445-52. PubMed ID: 16838826 [TBL] [Abstract][Full Text] [Related]
28. Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder. Bruce TJ; Spiegel DA; Gregg SF; Nuzzarello A Am J Psychiatry; 1995 Aug; 152(8):1156-60. PubMed ID: 7625463 [TBL] [Abstract][Full Text] [Related]
29. The treatment of benzodiazepine dependence. Ashton H Addiction; 1994 Nov; 89(11):1535-41. PubMed ID: 7841868 [TBL] [Abstract][Full Text] [Related]
30. Benzodiazepine use, cognitive impairment, and cognitive-behavioral therapy for anxiety disorders: issues in the treatment of a patient in need. Otto MW; Bruce SE; Deckersbach T J Clin Psychiatry; 2005; 66 Suppl 2():34-8. PubMed ID: 15762818 [TBL] [Abstract][Full Text] [Related]
32. International Study of Expert Judgement on Therapeutic Use of Benzodiazepines and Other Psychotherapeutic Medications: V. Treatment strategies in panic disorder, 1992-1997. Uhlenhuth EH; Balter MB; Ban TA; Yang K J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):27S-31S. PubMed ID: 9872710 [TBL] [Abstract][Full Text] [Related]
33. [Treatment of benzodiazepine dependence]. Soyka M; München B Fortschr Neurol Psychiatr; 2019 Apr; 87(4):259-270. PubMed ID: 30999380 [TBL] [Abstract][Full Text] [Related]
35. Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder. Roy-Byrne P; Russo J; Pollack M; Stewart R; Bystrisky A; Bell J; Rosenbaum J; Corrigan MH; Stolk J; Rush AJ; Ballenger J Psychol Med; 2003 Apr; 33(3):511-8. PubMed ID: 12701671 [TBL] [Abstract][Full Text] [Related]
36. How to face a patient with benzodiazepine dependence in primary health care? Strategies for withdrawal. Aguiluz J; Álvarez M; Pimentel E; Abarca C; Moore P Medwave; 2018 Jan; 18(1):e7159. PubMed ID: 29385122 [TBL] [Abstract][Full Text] [Related]
37. Withdrawal from long-term benzodiazepine use: randomised trial in family practice. Vicens C; Fiol F; Llobera J; Campoamor F; Mateu C; Alegret S; Socías I Br J Gen Pract; 2006 Dec; 56(533):958-63. PubMed ID: 17132385 [TBL] [Abstract][Full Text] [Related]
38. Long-term drug treatment of panic disorder. Burrows GD; Judd FK; Norman TR J Psychiatr Res; 1993; 27 Suppl 1():111-25. PubMed ID: 7908330 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis. Parr JM; Kavanagh DJ; Cahill L; Mitchell G; McD Young R Addiction; 2009 Jan; 104(1):13-24. PubMed ID: 18983627 [TBL] [Abstract][Full Text] [Related]
40. The role of captodiamine in the withdrawal from long-term benzodiazepine treatment. Mercier-Guyon C; Chabannes JP; Saviuc P Curr Med Res Opin; 2004 Sep; 20(9):1347-55. PubMed ID: 15383182 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]